ResearcherMemorial Sloan Kettering Cancer CenterActive in the last 2 years
Chun‐Hao Pan
Matched on ORCID iD 0000-0002-0776-9408; OpenAlex author ID A5076394795. Sources: OpenAlex.
Their work
- Papers
- 6
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 27
2019: 1 paper · 2020: 2 papers · 2021: none · 2022: 2 papers · 2023: none · 2024: none · 2025: none · 2026: 1 paper
Papers 6
- Mitochondrial-Localized Keratin 17 Promotes Chemoresistance in Basal-like Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-25-4534↗
- Targeting keratin 17-mediated reprogramming of de novo pyrimidine biosynthesis to overcome chemoresistance in pancreatic cancer Co-author DOI 10.1101/2022.08.24.504873↗
- Disassembly of embryonic keratin filaments promotes pancreatic cancer metastases Co-author DOI 10.1101/2022.08.27.504988↗
- An unbiased high-throughput drug screen reveals a potential therapeutic vulnerability in the most lethal molecular subtype of pancreatic cancer. Co-author DOI 10.1002/1878-0261.12743↗
- Altered RNA Splicing by Mutant p53 Activates Oncogenic RAS Signaling in Pancreatic Cancer. Co-author DOI 10.1016/j.ccell.2020.05.010↗
- Keratin 17 identifies the most lethal molecular subtype of pancreatic cancer. Co-author DOI 10.1038/s41598-019-47519-4↗
Closest collaborators
The 25 strongest of 27 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Luisa F. Escobar‐Hoyos · 6 shared papers, 2019–2026 · strength 0.74
- Paper Mitochondrial-Localized Keratin 17 Promotes Chemoresistance in Basal-like Pancreatic Cancer. DOI 10.1158/0008-5472.can-25-4534↗
- Paper Disassembly of embryonic keratin filaments promotes pancreatic cancer metastases DOI 10.1101/2022.08.27.504988↗
- Paper Targeting keratin 17-mediated reprogramming of de novo pyrimidine biosynthesis to overcome chemoresistance in pancreati… DOI 10.1101/2022.08.24.504873↗
- Kenneth Reed Shroyer · 6 shared papers, 2019–2026 · strength 0.74
- Paper Mitochondrial-Localized Keratin 17 Promotes Chemoresistance in Basal-like Pancreatic Cancer. DOI 10.1158/0008-5472.can-25-4534↗
- Paper Disassembly of embryonic keratin filaments promotes pancreatic cancer metastases DOI 10.1101/2022.08.27.504988↗
- Paper Targeting keratin 17-mediated reprogramming of de novo pyrimidine biosynthesis to overcome chemoresistance in pancreati… DOI 10.1101/2022.08.24.504873↗
- Lucia Roa‐Peña · 4 shared papers, 2019–2026 · strength 0.58
- Paper Mitochondrial-Localized Keratin 17 Promotes Chemoresistance in Basal-like Pancreatic Cancer. DOI 10.1158/0008-5472.can-25-4534↗
- Paper Disassembly of embryonic keratin filaments promotes pancreatic cancer metastases DOI 10.1101/2022.08.27.504988↗
- Paper Targeting keratin 17-mediated reprogramming of de novo pyrimidine biosynthesis to overcome chemoresistance in pancreati… DOI 10.1101/2022.08.24.504873↗
- Nina V. Chaika · 2 shared papers, 2022–2026 · strength 0.34
- Pankaj Kumar Singh · 2 shared papers, 2022–2026 · strength 0.34
- Ryan R. Kawalerski · 2 shared papers, 2020–2022 · strength 0.24
- Shayan Sarkar · 1 shared paper, 2026 · strength 0.21
- Lyanne Delgado Coka · 1 shared paper, 2026 · strength 0.21
- David Arthur Tuveson · 1 shared paper, 2026 · strength 0.21
- David Kuang-Fu Chang · 2 shared papers, 2020 · strength 0.16
- Andrew Victor Biankin · 2 shared papers, 2020 · strength 0.16
- Luke A. Torre-Healy · 1 shared paper, 2022 · strength 0.14
- Timothy Spicer · 1 shared paper, 2020 · strength 0.09
- Richard A. Moffitt · 1 shared paper, 2019 · strength 0.09
- John P. Morris · 1 shared paper, 2020 · strength 0.07
- Peter J. Bailey · 1 shared paper, 2020 · strength 0.07
- Scott W. Lowe · 1 shared paper, 2020 · strength 0.07
- Srivatsan Raghavan · 1 shared paper, 2020 · strength 0.07
- Olivera Grbovic-Huezo · 1 shared paper, 2020 · strength 0.07
- Gökçe Aşkan · 1 shared paper, 2020 · strength 0.07
- Andrew J. Aguirre · 1 shared paper, 2020 · strength 0.07
- Brian Matthew Wolpin · 1 shared paper, 2020 · strength 0.07
- Steven D Leach · 1 shared paper, 2020 · strength 0.07
- Channing J. Der · 1 shared paper, 2020 · strength 0.07
- G. Aaron Hobbs · 1 shared paper, 2020 · strength 0.07
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.